Cholesterol depletion disrupts caveolae and differentially impairs agonist-induced arterial contraction

Arterioscler Thromb Vasc Biol. 2002 Aug 1;22(8):1267-72. doi: 10.1161/01.atv.0000023438.32585.a1.

Abstract

Objective: This study assessed the role of cholesterol-rich membrane regions, including caveolae, in the regulation of arterial contractility. Methods and Results- Rat tail artery devoid of endothelium was treated with the cholesterol acceptor methyl-beta-cyclodextrin, and the effects on force and Ca2+ handling were evaluated. In cholesterol-depleted preparations, the force responses to alpha1-adrenergic receptors, membrane depolarization, inhibition of myosin light chain phosphatase, and activation of G proteins with a mixture of 20 mmol/L NaF and 60 micro mol/L AlCl3 were unaffected. In contrast, responses to 5-hydroxytryptamine (5-HT), vasopressin, and endothelin were reduced by >50%. The rise in global intracellular free Ca2+ concentration in response to 5-HT was attenuated, as was the generation of Ca2+ waves at the cellular level. By electron microscopy, cholesterol depletion was found to disrupt caveolae. The 5-HT response could be restored by exogenous cholesterol, which also restored caveolae. Western blots showed that the levels of 5-HT2A receptor and of caveolin-1 were unaffected by cholesterol extraction. Sucrose gradient centrifugation showed enrichment of 5-HT2A receptors, but not alpha1-adrenergic receptors, in the caveolin-1-containing fractions, suggesting localization of the former to caveolae.

Conclusions: These results show that a subset of signaling pathways that regulate smooth muscle contraction depends specifically on cholesterol. Furthermore, the cholesterol-dependent step in serotonergic signaling occurs early in the pathway and depends on the integrity of caveolae.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Agonists / pharmacology
  • Animals
  • Arteries / physiology
  • Caveolae / metabolism*
  • Cholesterol / metabolism*
  • Cyclodextrins / pharmacology
  • Female
  • Imidazoles / pharmacology
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / physiology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Serotonin / metabolism
  • Tail / blood supply
  • Vasoconstriction / drug effects
  • Vasoconstriction / physiology*

Substances

  • Adrenergic alpha-Agonists
  • Cyclodextrins
  • Imidazoles
  • Receptors, Serotonin
  • Cholesterol
  • cirazoline